Zhongwang Wang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta-Analyses.
Journal: Cancer medicine
Published: November 10, 2025
Intracellular iron homeostasis-regulated epigenetic reprogramming contributes to -7/del(7q) leukemia.
Journal: Nature communications
Published: October 05, 2025
Prolonged duration of pharmacological thromboprophylaxis following oncologic surgery: A systematic review and meta-analysis of RCTs.
Journal: Thrombosis research
Published: June 20, 2025
Efficacy and safety of chimeric antigen receptor T-cell in the treatment of hematologic malignancy: an umbrella review of systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: April 09, 2025
Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021.
Journal: Frontiers in genetics
Published: March 20, 2025
Dietary Flavonoid Intake and Anemia Risk in Children and Adolescents: Insights from National Health and Nutrition Examination Survey.
Journal: Antioxidants (Basel, Switzerland)
Published: February 06, 2025
A comprehensive and systematic analysis of Dihydrolipoamide S-acetyltransferase (DLAT) as a novel prognostic biomarker in pan-cancer and glioma.
Journal: Oncology research
Published: November 28, 2023
Venetoclax overcomes resistance to all-trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion.
Journal: Molecular carcinogenesis
Published: November 06, 2023
Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials.
Journal: Frontiers in oncology
Published: December 19, 2022
DNMT3AR882H accelerates angioimmunoblastic T-cell lymphoma in mice.
Journal: Oncogene
Published: December 02, 2022
KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 19, 2022
Last Updated: 09/26/2026